gms | German Medical Science

67th Annual Meeting of the German Society of Neurosurgery (DGNC)
Joint Meeting with the Korean Neurosurgical Society (KNS)

German Society of Neurosurgery (DGNC)

12 - 15 June 2016, Frankfurt am Main

Treatment of sacroiliac joint pain with peripheral nerve stimulation – 36 months experience

Meeting Abstract

  • Marin Guentchev - Klinik für Neurchirurgie, Klinikum Idar-Oberstein, Germany
  • Christian Preuss - Klinik für Neurchirurgie, Klinikum Idar-Oberstein, Germany
  • Rainer Rink - Klinik für Neurchirurgie, Klinikum Idar-Oberstein, Germany
  • Levente Peter - Klinik für Neurchirurgie, Klinikum Idar-Oberstein, Germany
  • Ernst-Ludwig Wocker - Klinik für Radiologie, Klinikum Idar-Oberstein, Germany
  • Jochen Tuettenberg - Klinik für Neurchirurgie, Klinikum Idar-Oberstein, Germany

Deutsche Gesellschaft für Neurochirurgie. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 1. Joint Meeting mit der Koreanischen Gesellschaft für Neurochirurgie (KNS). Frankfurt am Main, 12.-15.06.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. DocDI.04.07

doi: 10.3205/16dgnc116, urn:nbn:de:0183-16dgnc1162

Published: June 8, 2016

© 2016 Guentchev et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Sacroiliac joint (SIJ) pain affects older adults with a prevalence of up to 36% among patients with chronic low back pain. While pain medication, joint blocks and denervation procedures achieve pain relief in most patients, some cases fail to improve. Recently we were able to show that peripheral nerve stimulation has a 85.7% success rate in patients with severe conservative therapy-refractory SIJ pain after one year of treatment. In this study we investigated the effect of this novel treatment method for a period of up to 36 months.

Method: Here we present 12 consecutive patients with severe conservative therapy-refractory pain receiving a SIJ peripheral nerve stimulation. Follow-up was at least 36 months in 6 patients, at least 24 months in nine patients and at least 12 months in 12 patients. Patient satisfaction, pain and quality of life were evaluated by means of the International Patient Satisfaction Index (IPSI), Visual Analog Scale (VAS) and Oswestry Disability Index 2.0 (ODI) using standard questionnaires. For stimulation we placed an 8 pole peripheral nerve electrode parallel to the SIJ.

Results: One year postoperatively our patients reported an average VAS reduction from 8,8 to 1.6 (t-test, p<0.0001, as compared to the preoperative data). In 11 out of 12 patients (91.6%) the therapy was rated as effective (IPSI score of 1 or 2). After 24 months the average the VAS score was 2.1 (p<0.0001). In 8 out of 9 patients (88,9%) the therapy was rated as effective. Thirty-six months after stimulation 5 out of 6 patients (83.3%) considered their treatment a success with an average VAS 2.5 (p<0.005).

Conclusions: Our current data show that peripheral nerve stimulation is an effective long-term treatment for therapy-refractory SIJ pain. The consistently high response rate and long follow-up time suggest that this result is unlikely that this is due to a placebo effect.